Based on our experience, we have been able to develop some real staging-based guidelines for the therapeutic treatment of keratoconus and, in our opinion, corneal collagen cross-linking is mainly effective in the first and second stage of the disease. We believe that an early keratoconus diagnosis is necessary in order to optimize cross-linking efficacy, delay keratoconus progression and reduce the need for corneal transplants. We truly believe that this new equipment represents one of the most advanced technologies available for the cross-linking technique and, as we assimilate further patient data, no doubt more widespread use will follow.

Acknowledgements

Our thanks go to Luciano Sassano (C.S.O., Italy) and Riccardo Nicoletti (C.S.O., Italy) for all of their technical support.

AUTHORS
Aldo Caporossi MD, FRCS, Cosimo Mazzotta MD, PhD & Stefano Baiocchi MD, PhD work at Siena University, Siena, Italy. Dr Caporossi may be reached by E-mail: caporossi@unisi.it

Aldo Caporossi MD, FRCS

Cosimo Mazzotta MD, PhD

Stefano Baiocchi MD, PhD

References

1. G. Wollensak, E. Spoerl, T. Seiler. Am. J. Ophthalmol., 2003;135:620-627.

2. A. Caporossi, et al. J. Cataract Refract. Surg. 2006;32:837-845.

3. C. Mazzotta, et al. Eur. J. Ophthalmol. 2006;16(4):530-535.

4. C. Mazzotta, et al. Cornea 2007;26(4):390-397.

5. R. Mencucci, C. Mazzotta et al. J. Cataract Refract. Surg. 2007;33(6):1005-8.

6. A. Caporossi, S. Baiocchi, C. Mazzotta. La Voce A.I.C.C.E.R., 2006;4.